-Financial results to be released on March 27, 2013-
TORONTO, March 25, 2013 /CNW/ - Prism Medical Ltd. (TSXV: PM) will
release its fiscal 2012 fourth quarter and year-end financial results
on Wednesday, March 27, 2013. The Company will subsequently hold a conference call on Thursday,
March 28, 2013, at 9:00 a.m. Eastern Time to discuss the results. The
call will be hosted by Mr. Stuart Meldrum, Chief Executive Officer, and
Mr. George Chiarucci, Chief Financial Officer. A question and answer
period will follow the corporate update.
CONFERENCE CALL DETAILS:
Thursday, March 28, 2013
9:00 a.m. Eastern Time
(647) 427-7450 or (888) 231-8191
(416) 849-0833 or (855) 859-2056
A link to the live audio webcast of the conference call will be
available on the Company's website at www.prismmedicalltd.com as well as at www.newswire.ca. Please connect at least 15 minutes prior to the conference call to
ensure adequate time for any software download that may be required to
hear the webcast.
About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of
durable medical equipment and related services to the mobility
challenged in Canada, the U.S. and the U.K., with more than 100,000
installations and 200,000 product solutions sold. The Prism Medical
brands include Waverley Glen and ErgoSafe, North America's leading
supplier of lifting, handling and repositioning aid products and
services across Canada and the U.S. Freeway and Prism Service & Repair
are leading suppliers of moving and handling products and services in
the U.K. For further information visit: www.prismmedicalltd.com.
This document contains forward-looking statements relating to our
operations and to the environment in which we operate and our strategy,
action plans and investments, which may involve estimates, forecasts
and projections. These statements are not guarantees of future
performance and involve risks and uncertainties that are difficult to
predict and/or are beyond our control. A number of important factors
could cause actual outcomes and results to differ materially from those
expressed in these forward-looking statements. These factors include
those set forth in this report and our other public filings.
Consequently, readers should not place any undue reliance on such
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
SOURCE: Prism Medical Ltd.
For further information:
Chief Financial Officer
416-260-2145 ext. 229